Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union

ObjectivesTo examine and compare the use of health technology assessment (HTA) for the reimbursement of new medicines in selected European Union member states with decades of experience in the use of HTA and in countries that have used it regularly since 2000.MethodsThe selected countries were categorized into “earlier” adopters (group A: England, Germany, France, and Sweden) and more “recent” adopters (group B: Poland, Bulgaria, Hungary, and...